Net profit of Aurobindo Pharma declined 10.28% to Rs 824.75 crore in the quarter ended June 2025 as against Rs 919.22 crore during the previous quarter ended June 2024. Sales rose 4.48% to Rs 7791.77 crore in the quarter ended June 2025 as against Rs 7457.65 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 7791.77 | 7457.65 | 4 |
| OPM % | 20.57 | 21.70 | - |
| PBDT | 1612.50 | 1728.07 | -7 |
| PBT | 1206.80 | 1323.89 | -9 |
| NP | 824.75 | 919.22 | -10 |